Systematic review of the clinical effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 in immunocompromised patients

Rhea Suribhatla, Thomas Starkey, Maria C Ionescu, Antonio Pagliuca, Alex Richter, Lennard YW Lee
doi: https://doi.org/10.1101/2022.11.07.22281786

Article usage

Article usage: November 2022 to August 2025

AbstractFullPdf
Nov 20223200431116
Dec 20226247220
Jan 202351615144
Feb 20233841497
Mar 2023266767
Apr 20231652760
May 2023104234
Jun 20236859
Jul 202384619
Aug 2023911119
Sep 202371531
Oct 2023746123
Nov 2023941730
Dec 202362111
Jan 202446132
Feb 202448459
Mar 202436280
Apr 202440418
May 202443210
Jun 202454413
Jul 202448112
Aug 202475415
Sep 202462515
Oct 20244935
Nov 202446216
Dec 202434310
Jan 202539812
Feb 2025352510
Mar 2025493018
Apr 2025521721
May 2025451127
Jun 2025411916
Jul 202523816
Aug 2025728
Back to top
Posted November 07, 2022.
Download PDF
Data/Code
Email
Systematic review of the clinical effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 in immunocompromised patients
Rhea Suribhatla, Thomas Starkey, Maria C Ionescu, Antonio Pagliuca, Alex Richter, Lennard YW Lee
medRxiv 2022.11.07.22281786; doi: https://doi.org/10.1101/2022.11.07.22281786
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area